List of Excipients in API doxylamine succinate and pyridoxine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doxylamine succinate and pyridoxine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | ALCOHOL | |
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | AMMONIA | |
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | BUTYL ALCOHOL | |
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | CARNAUBA WAX | |
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | CELLULOSE, MICROCRYSTALLINE | |
| Duchesnay USA Inc | DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | 55494-100 | CROSCARMELLOSE SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing doxylamine succinate and pyridoxine hydrochloride
Detailed excipient profiles for doxylamine succinate and pyridoxine hydrochloride
Excipient focus: ALCOHOL
doxylamine succinate and pyridoxine hydrochloride drug variants containing ALCOHOL
doxylamine succinate and pyridoxine hydrochloride drug variants not containing ALCOHOL
Excipient focus: AMMONIA
doxylamine succinate and pyridoxine hydrochloride drug variants containing AMMONIA
doxylamine succinate and pyridoxine hydrochloride drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride drug variants containing BUTYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride drug variants not containing BUTYL ALCOHOL
Excipient focus: CARNAUBA WAX
doxylamine succinate and pyridoxine hydrochloride drug variants containing CARNAUBA WAX
doxylamine succinate and pyridoxine hydrochloride drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
doxylamine succinate and pyridoxine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Bionpharma Inc | doxylamine succinate and pyridoxine hydrochloride | 69452-206 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
doxylamine succinate and pyridoxine hydrochloride drug variants containing CROSCARMELLOSE SODIUM
doxylamine succinate and pyridoxine hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxylamine succinate and pyridoxine hydrochloride | 0378-4615 |
| Bionpharma Inc | doxylamine succinate and pyridoxine hydrochloride | 69452-206 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 27
doxylamine succinate and pyridoxine hydrochloride drug variants containing D&C RED NO. 27
doxylamine succinate and pyridoxine hydrochloride drug variants not containing D&C RED NO. 27
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
doxylamine succinate and pyridoxine hydrochloride drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: DIMETHICONE
doxylamine succinate and pyridoxine hydrochloride drug variants containing DIMETHICONE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing DIMETHICONE
Excipient focus: FD&C BLUE NO. 2
doxylamine succinate and pyridoxine hydrochloride drug variants containing FD&C BLUE NO. 2
doxylamine succinate and pyridoxine hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERRIC OXIDE RED
doxylamine succinate and pyridoxine hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate and pyridoxine hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERROSOFERRIC OXIDE
doxylamine succinate and pyridoxine hydrochloride drug variants containing FERROSOFERRIC OXIDE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Bryant Ranch Prepack | doxylamine succinate and pyridoxine hydrochloride | 63629-8358 |
| Analog Pharma | doxylamine succinate and pyridoxine hydrochloride | 70505-100 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
doxylamine succinate and pyridoxine hydrochloride drug variants containing HYPROMELLOSE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
doxylamine succinate and pyridoxine hydrochloride drug variants containing HYPROMELLOSES
doxylamine succinate and pyridoxine hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride drug variants containing ISOPROPYL ALCOHOL
doxylamine succinate and pyridoxine hydrochloride drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: MAGNESIUM STEARATE
doxylamine succinate and pyridoxine hydrochloride drug variants containing MAGNESIUM STEARATE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM TRISILICATE
doxylamine succinate and pyridoxine hydrochloride drug variants containing MAGNESIUM TRISILICATE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing MAGNESIUM TRISILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Bionpharma Inc | doxylamine succinate and pyridoxine hydrochloride | 69452-206 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
doxylamine succinate and pyridoxine hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bionpharma Inc | doxylamine succinate and pyridoxine hydrochloride | 69452-206 |
| >Company | >Ingredient | >NDC |
doxylamine succinate and pyridoxine hydrochloride drug variants not containing MANNITOL
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
doxylamine succinate and pyridoxine hydrochloride drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
doxylamine succinate and pyridoxine hydrochloride drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| Par Pharmaceutical Inc | doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg | 49884-186 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
doxylamine succinate and pyridoxine hydrochloride drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| Par Pharmaceutical Inc | doxylamine succinate and pyridoxine hydrochloride, delayed release tablets 10 mg/10 mg | 49884-186 |
| >Company | >Ingredient | >NDC |
doxylamine succinate and pyridoxine hydrochloride drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: POLYETHYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride drug variants containing POLYETHYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
doxylamine succinate and pyridoxine hydrochloride drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| >Company | >Ingredient | >NDC |
doxylamine succinate and pyridoxine hydrochloride drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
doxylamine succinate and pyridoxine hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Bryant Ranch Prepack | doxylamine succinate and pyridoxine hydrochloride | 63629-8358 |
| Analog Pharma | doxylamine succinate and pyridoxine hydrochloride | 70505-100 |
| >Company | >Ingredient | >NDC |
doxylamine succinate and pyridoxine hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
doxylamine succinate and pyridoxine hydrochloride drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-100 |
| Bryant Ranch Prepack | doxylamine succinate and pyridoxine hydrochloride | 63629-8358 |
| Analog Pharma | doxylamine succinate and pyridoxine hydrochloride | 70505-100 |
| >Company | >Ingredient | >NDC |
doxylamine succinate and pyridoxine hydrochloride drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
doxylamine succinate and pyridoxine hydrochloride drug variants containing POLYSORBATE 80
doxylamine succinate and pyridoxine hydrochloride drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Duchesnay USA Inc | doxylamine succinate and pyridoxine hydrochloride | 55494-120 |
| Bionpharma Inc | doxylamine succinate and pyridoxine hydrochloride | 69452-206 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride drug variants containing PROPYLENE GLYCOL
doxylamine succinate and pyridoxine hydrochloride drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
doxylamine succinate and pyridoxine hydrochloride drug variants containing SHELLAC
doxylamine succinate and pyridoxine hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
doxylamine succinate and pyridoxine hydrochloride drug variants containing SILICON DIOXIDE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxylamine succinate and pyridoxine hydrochloride | 0378-4615 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
doxylamine succinate and pyridoxine hydrochloride drug variants containing SODIUM BICARBONATE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxylamine succinate and pyridoxine hydrochloride | 0378-4615 |
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
doxylamine succinate and pyridoxine hydrochloride drug variants containing SODIUM LAURYL SULFATE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxylamine succinate and pyridoxine hydrochloride | 0378-4615 |
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
doxylamine succinate and pyridoxine hydrochloride drug variants containing TALC
doxylamine succinate and pyridoxine hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
doxylamine succinate and pyridoxine hydrochloride drug variants containing TITANIUM DIOXIDE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxylamine succinate and pyridoxine hydrochloride | 0378-4615 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
doxylamine succinate and pyridoxine hydrochloride drug variants containing TRIETHYL CITRATE
doxylamine succinate and pyridoxine hydrochloride drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | doxylamine succinate and pyridoxine hydrochloride | 0378-4615 |
| Actavis Pharma Inc | doxylamine succinate and pyridoxine hydrochloride | 0591-2132 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
